Drugs with known pharmacological profiles, such as monensin, disulfiram and salinomycin, show cancer-selective inhibition of prostate cancer cell growth by increasing oxidative stress

Kirsi Ketola, Paula Vainio, Pasi Halonen, Pekka Kohonen, Vidal Fey, Roland Grafström, Merja Perälä, Olli Kallioniemi, Kristiina Iljin

    Research output: Contribution to journalOther journal contributionScientificpeer-review

    Original languageEnglish
    Article number234
    Pages (from-to)61-62
    JournalEuropean Journal of Cancer: Supplement
    Issue number5
    Publication statusPublished - 2010
    MoE publication typeNot Eligible
    Event21st Meeting of the European Association for Cancer Research, EACR-21 - Oslo, Norway
    Duration: 26 Jun 201029 Jun 2010

    Cite this